13F filer · CIK 1645157
Foresite Capital Management III, LLC
Larkspur, CA · filing since Q4 2015 · last filing Nov 14, 2022
Reported value
$37.9M
+$10.3M vs prior
Positions
4
New / sold out
0 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $0
Top-10 weight
100.0%
Biggest buys vs Q2 2022
No new or increased positions this quarter.
Biggest sells vs Q2 2022
No reduced or sold positions this quarter.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2022
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Ascendis Pharma A/SSPONSORED ADS | 133,691 | $13.8M | 36.44% |
| 2 | Verona Pharma PLC.SPONSORED ADS | 1,111,112 | $11.4M | 29.98% |
| 3 | Natera, Inc.COM | 159,160 | $7.0M | 18.41% |
| 4 | Cymabay Therapeutics, Inc.COM | 1,641,804 | $5.7M | 15.17% |